Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Behnes

Showing results (41-50 of 330) with videos related to

Pageof 33
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 12, 2016
Novel retrograde approach for percutaneous treatment of chronic total occlusions of the right coronary artery using ipsilateral collateral connections: a European centre experienceKambis Mashayekhi, Michael Behnes, Ibrahim Akin, et al.
Current Pharmaceutical Biotechnology|July 4, 2017
Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac DeathMathieu Kruska, Ibrahim El-Battrawy, Michael Behnes, et al.
Cardiology Clinics|October 10, 2020
Patient Selection for Protected Percutaneous Coronary Intervention: Who Benefits the Most?Seung-Hyun Kim, Stefan Baumann, Michael Behnes, et al.
Future Cardiology|March 19, 2020
Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fractionMohammad Abumayyaleh, Ibrahim El-Battrawy, Michael Behnes, et al.
Interventional Cardiology Clinics|October 15, 2022
Patient Selection for Protected Percutaneous Coronary Intervention: Who Benefits the Most?Seung-Hyun Kim, Stefan Baumann, Michael Behnes, et al.
Current Pharmaceutical Biotechnology|July 4, 2017
Biomarkers in Stable Coronary Artery DiseaseJonas Rusnak, Christian Fastner, Michael Behnes, et al.
International Journal of Cardiology|August 27, 2013
Intercellular adhesion molecule 1 (ICAM-1)--a new substrate for the development of ventricular fibrillation?Michael Behnes, Christian Ruff, Siegfried Lang, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 27, 2016
Veno-venous double lasso pull-and-push technique for transseptal retrieval of an embolized Watchman occluderChristian Fastner, Ralf Lehmann, Michael Behnes, et al.
International Journal of Cardiology|January 6, 2012
Tackling myocardial metabolism: one year evaluation of free fatty acids, norephinephrine and NT-proBNP in ventricular fibrillation during STEMIMichael Behnes, Thorsten Kälsch, Siegfried Lang, et al.
Circulation|September 30, 2015
Response to letter regarding article, "effect of tumor necrosis factor inhibitor treatment on proximal right coronary chronic total occlusion in a patient with rheumatoid arthritis"Michael Behnes, Ibrahim Akin, Martin Borggrefe, et al.
Pageof 33

Showing results (41-50 of 330) with videos related to

Sort By:
Pageof 33
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 12, 2016
Novel retrograde approach for percutaneous treatment of chronic total occlusions of the right coronary artery using ipsilateral collateral connections: a European centre experienceKambis Mashayekhi, Michael Behnes, Ibrahim Akin, et al.
Current Pharmaceutical Biotechnology|July 4, 2017
Biomarkers in Cardiomyopathies and Prediction of Sudden Cardiac DeathMathieu Kruska, Ibrahim El-Battrawy, Michael Behnes, et al.
Cardiology Clinics|October 10, 2020
Patient Selection for Protected Percutaneous Coronary Intervention: Who Benefits the Most?Seung-Hyun Kim, Stefan Baumann, Michael Behnes, et al.
Future Cardiology|March 19, 2020
Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fractionMohammad Abumayyaleh, Ibrahim El-Battrawy, Michael Behnes, et al.
Interventional Cardiology Clinics|October 15, 2022
Patient Selection for Protected Percutaneous Coronary Intervention: Who Benefits the Most?Seung-Hyun Kim, Stefan Baumann, Michael Behnes, et al.
Current Pharmaceutical Biotechnology|July 4, 2017
Biomarkers in Stable Coronary Artery DiseaseJonas Rusnak, Christian Fastner, Michael Behnes, et al.
International Journal of Cardiology|August 27, 2013
Intercellular adhesion molecule 1 (ICAM-1)--a new substrate for the development of ventricular fibrillation?Michael Behnes, Christian Ruff, Siegfried Lang, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 27, 2016
Veno-venous double lasso pull-and-push technique for transseptal retrieval of an embolized Watchman occluderChristian Fastner, Ralf Lehmann, Michael Behnes, et al.
International Journal of Cardiology|January 6, 2012
Tackling myocardial metabolism: one year evaluation of free fatty acids, norephinephrine and NT-proBNP in ventricular fibrillation during STEMIMichael Behnes, Thorsten Kälsch, Siegfried Lang, et al.
Circulation|September 30, 2015
Response to letter regarding article, "effect of tumor necrosis factor inhibitor treatment on proximal right coronary chronic total occlusion in a patient with rheumatoid arthritis"Michael Behnes, Ibrahim Akin, Martin Borggrefe, et al.
Pageof 33